Relationship Between CB1 and S1P Receptors in the Central Nervous System by Collier, Lauren Michele
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2006
Relationship Between CB1 and S1P Receptors in
the Central Nervous System
Lauren Michele Collier
Virginia Commonwealth University
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Medical Pharmacology Commons
© The Author
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses
and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/733



Table of Contents 
......................................................... 1 . List of tables iv 
........................................................ 2 . List of figures v 
. . 
................................................ 3 . List of abbreviations vn 
............................................................... 4 . Abstract xi 
............................................. 5 . Chapter 1 : Introduction 1 
........................................ 6 . G-protein-coupled receptors 1 
......................................................... 7 . Cannabinoids 11 
........................................... 8 . Sphingosine- 1 -phosphate 18 
................................................... 9 . Purpose of Project 23 
................................. 10 . Chapter 2: Materials and Methods 27 
............................................................... 1 1 . Materials 27 
............................................................... 12 . Methods 29 
.................................................... 13 . Chapter 3: Results 33 
............................................ 14 . Autoradiographic results 33 
.................. 15 . [ 3 5 ~ ] ~ ~ ~ y ~  agonist-stimulated binding results 41 
............................................... 16 . Chapter 4: Discussion 56 
..................................................... 17 . Future directions 66 
................................................... . 18 List of References 71 
.................................................................... . 19 Vita 82 
List of Tables 
1 . Summary of G a  subtypes .......................................................... 9 
2 . Net WIN- and SIP-stimulated [ 3 5 ~ ] ~ ~ ~ ~  autoradiography ............... 34 
3 . Results of autoradiography additivity study ................................... 37 
4 . Em,, values from cannabinoid and SIP- stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding 
in CB1 and SIPl knockout and wild type studies ................................. 42 
5 . ECso values from cannabinoid and S 1P- stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding 
in CBI and S lP1 knockout and wild type studies .............................. 42 
6 . Theoretical vs actual additivity of percent stimulation ........................ 52 
7 . Percent additivity .................................................................. 53 
List of Figures 
...................................... 1 . CB 11s 1 P receptor amino acid sequence 3 
2 . GPCR activation cycle ......................................................... 7 
.................................... . 3 Agonist-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding 8 
...................................... . 4 Phylogenetic tree of lysolipid receptors 24 
......................................... . 5 Arachidonic acidtceramide structure 25 
6 . Autoradiogram of agonist-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding in caudate- 
.......................................................................... putamen 35 
7 . Autoradiogram of agonist-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding in 
..................................................................... hippocampus 35 
8 . Autoradiography results: WIN- vs . S 1P-stimulation [ 3 5 ~ ] ~ ~ ~ y ~  
.......................................................................... binding 36 
......................................... . 9 Autoradiography results: Additivity 38 
10 . Autoradiography results: SR14 17 16A reversal of S 1 P-stimulated [ 3 5 ~ ] ~ ~ @ ~  
.......................................................................... binding 40 
11 . WIN-stimulated [ 3 5 ~ ] ~ ~ @ ~  binding in CB1 knockout and wild type spinal 
............................................................................. cords 43 
12 . CP-stimulated [ 3 5 ~ ] ~ ~ P y ~  binding in CB1 knockout and wild type spinal 
........................................................................... cords -43 
13 . S 1P-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding in CBI knockout and wild type spinal 
........................................................................... cords -44 
14 . SEW-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  in CB1 knockout and wild type spinal 
cords ............................................................................ 44 
15 . WIN-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding in SIPl knockout and wild type spinal 
........................................................................... cords -45 
16 . CP-stimulated [ 3 5 ~ ] ~ ~ ~ ~  binding in SIPl knockout and wild type spinal 
............................................................................ cords 45
17 . S 1 P-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding in S lPl knockout and wild type spinal 
........................................................................... cords -46 
18 . SEW-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding in S lPl knockout and wild type spinal 
........................................................................... cords -46 
19 . SRlISFG! reversal of WIN-stimulated G-protein activation ............. 48 
20 . SRlISR2 reversal of S 1P-stimulated G-protein activation .............. 49 
21 . Theoretical vs Actual Additivity ............................................ 54 
............................................................. 22 . Percent Additivity 55 


Abstract 
Relationship Between CB I and S 1P Receptors in the Central Nervous System 
By Lauren Michele Collier, MS 
A thesis submitted in partial fulfillment of the requirements for the degree of Masters 
in Pharmacology and Toxicology at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Major Director: Laura J. Sim-Selley 
Associate Professor, Department of Pharmacology and Toxicology 
There is significant sequence homology and anatomical co-distribution 
between cannabinoid (CB I)  and sphingosine- 1 -phosphate (S 1 P) receptors in 
the CNS, but potential functional relationships between these lysolipid 
receptors have not been examined. Therefore, to investigate possible 
relationships between these two systems at the level of G-protein activation, 
agonist-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding and autoradiography were conducted. 
Autoradiographic studies were first performed to localize receptor-mediated 
G-protein activation in mouse brain. Coronal brain slices were processed for 
stimulation of [ 3 5 ~ ] ~ ~ ~ y ~  binding using the synthetic cannabinoid agonist 
WIN 55,212-2 (WIN) or SIP. High levels of WIN- and SIP-stimulated 
[ 3 5 ~ ] ~ ~ ~ y ~  binding were observed in the caudate putamen, hippocampus, 
substantia nigra, and cerebellum. To further characterize the relationship 
between S 1P- and CB1-mediated G-protein activation, spinal cords from adult 
male CBI receptor knockout mice, CNS-deleted SIPl receptor knockout mice 
and wild type (2.57 mice were collected, and assessed using agonist-stimulated 
[ 3 5 ~ ] ~ ~ ~ y ~  binding. Results from this experiment revealed that the SIPl 
receptor is predominant in mouse spinal cord. To further investigate potential 
CBl and SIP receptor interactions spinal cords were collected from adult male 
ICR mice. Additivity studies were preformed using agonist-stimulated 
[ 3 5 ~ ] ~ ~ ~ ~  binding. Results showed significantly less than additive 
stimulation when spinal cord tissue was treated with both WIN and SIP. 
These results suggest an interaction between the CBI and S 1 P receptors in the 
mouse spinal cord. The effect of cannabinoid antagonists, SR14 17 16A (CB 1) 
and SR144528 (CB2) on SIP- and WIN-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding were 
also examined in mouse spinal cord homogenates. These results showed that 
there was no significant difference between SIP-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  
binding in the presence of SR141716A or SR144528 compared to vehicle 
control. This shows that S 1P produced stimulation independent of the CBl or 
CB2 receptor. In addition WIN-stimulated [ 3 5 ~ ] ~ ~ ~ y ~  binding was not 
affected by SR144528, but was inhibited by SR141716A, confirming that this 
action is due to the CBI receptor. The combined results of this project 
demonstrate an interaction between CBI and SIP receptors in certain CNS 
regions where they are co-distributed, such as the caudate putamen, 
hippocampus, substantia nigra, cerebellum and spinal cord. These results may 
be due to convergence on a common pool of G-proteins via dimerization or 
co-localization in lipid rafts, or a possible direct ligand-receptor interaction. 
Chapter 1 Introduction 
G-protein Coupled receptors 
There are over 800 genes in the genome that code for the superfamily of G- 
protein-coupled receptors (GPCR). These receptors, also known as heptahelical 
receptors, are characterized by their seven-trans-membrane (7TM) configuration, with an 
extracellular N-terminus an intracellular C-terminus, and their functional activation of 
heterotrimeric G-proteins (Lefkowitz et al., 1993; van Neuren et al., 1999). Members of 
this family include receptors for neurotransmitters, hormones, chemokines and many 
other endogenous, as well as exogenous, ligands. GPCRs constitute a large and widely 
distributed superfamily of membrane-bound receptors and are the most common target of 
therapeutic drugs (van Neuren et al., 1999; Pierce et al., 2002). 
In this project we examined two GPCRs in the CNS: the cannabinoid-1-receptor 
(CB 1 receptor) and the sphingosine- 1 -phosphate receptors (S 1P1-5 receptor). Figure 1 
shows the amino acid structures of the CBl and S I P  receptors 
(www.wdv.coni/CellWorld/Receptors). Both of these receptor systems activate G- 
proteins (Matsuda et al., 1990; Brambiet et al., 1995; Pyne and Pyne, 2000) and have 
endogenous ligands that are lysolipids derived from similar precursors (Hla, 2004; 
DiMarzo et al., 1999; Devane et al., 1992; Stella et al., 1997). The CBl and SIP 
receptors are co-distributed in regions of the CNS and both have been shown to 
congregate in lipid rafts (Ohanian et al., 2001; Barnett-Norris et al., 2005). Due to the 
recent advances in the clinical applications using the sphingosine analog FTY720 (2- 
amino-2-(2-[4-octyphenyl]ethyl)-1,3-propanediol), as an immunosupresant drug; it is 

















































































